Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicare | 51 | 2024 | 6785 | 4.550 |
Why?
|
Economics, Hospital | 6 | 2024 | 212 | 2.930 |
Why?
|
Patient Readmission | 23 | 2024 | 3322 | 2.890 |
Why?
|
Myocardial Infarction | 30 | 2024 | 11890 | 2.880 |
Why?
|
Cardiovascular Diseases | 33 | 2024 | 15760 | 2.880 |
Why?
|
Cardiovascular System | 5 | 2024 | 850 | 2.590 |
Why?
|
Hyperlipidemias | 4 | 2024 | 782 | 2.440 |
Why?
|
Medicaid | 16 | 2023 | 2815 | 2.430 |
Why?
|
United States | 125 | 2024 | 72448 | 2.370 |
Why?
|
Heart Failure | 25 | 2024 | 11848 | 1.990 |
Why?
|
Quality of Health Care | 13 | 2024 | 4360 | 1.920 |
Why?
|
Hospitals | 15 | 2024 | 3928 | 1.770 |
Why?
|
Health Policy | 6 | 2024 | 2677 | 1.710 |
Why?
|
Quality Indicators, Health Care | 6 | 2020 | 1822 | 1.710 |
Why?
|
Healthcare Disparities | 12 | 2022 | 3386 | 1.680 |
Why?
|
Hospitalization | 23 | 2024 | 10789 | 1.600 |
Why?
|
Homeless Youth | 2 | 2022 | 46 | 1.600 |
Why?
|
Medicare Part C | 5 | 2023 | 322 | 1.560 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5890 | 1.490 |
Why?
|
Fee-for-Service Plans | 11 | 2024 | 705 | 1.460 |
Why?
|
Reimbursement Mechanisms | 3 | 2020 | 664 | 1.360 |
Why?
|
Insurance, Health | 5 | 2024 | 2501 | 1.340 |
Why?
|
Eligibility Determination | 4 | 2024 | 419 | 1.330 |
Why?
|
Pneumonia | 8 | 2024 | 2131 | 1.280 |
Why?
|
Prescription Drugs | 4 | 2024 | 630 | 1.230 |
Why?
|
Reimbursement, Incentive | 4 | 2024 | 542 | 1.230 |
Why?
|
Delivery of Health Care | 7 | 2024 | 5325 | 1.190 |
Why?
|
Poverty | 9 | 2024 | 2695 | 1.070 |
Why?
|
Cross-Sectional Studies | 30 | 2024 | 25941 | 1.070 |
Why?
|
Cardiology | 3 | 2024 | 1723 | 1.000 |
Why?
|
Humans | 167 | 2024 | 760613 | 0.970 |
Why?
|
Coronary Artery Bypass | 6 | 2024 | 2272 | 0.950 |
Why?
|
Rural Population | 4 | 2024 | 2268 | 0.940 |
Why?
|
Hypertension | 6 | 2024 | 8595 | 0.930 |
Why?
|
Patient Protection and Affordable Care Act | 7 | 2023 | 1200 | 0.910 |
Why?
|
Social Class | 3 | 2024 | 2005 | 0.900 |
Why?
|
Health Services Accessibility | 12 | 2024 | 5397 | 0.860 |
Why?
|
Pulmonary Embolism | 3 | 2024 | 2543 | 0.860 |
Why?
|
Hospital Mortality | 14 | 2024 | 5418 | 0.850 |
Why?
|
Empiricism | 1 | 2022 | 7 | 0.840 |
Why?
|
Aged | 68 | 2024 | 169143 | 0.830 |
Why?
|
Budgets | 1 | 2024 | 230 | 0.800 |
Why?
|
Stroke | 5 | 2024 | 9952 | 0.790 |
Why?
|
Drug Costs | 4 | 2024 | 1185 | 0.790 |
Why?
|
Health Expenditures | 10 | 2024 | 2362 | 0.790 |
Why?
|
Prospective Payment System | 1 | 2022 | 136 | 0.770 |
Why?
|
Heart | 6 | 2024 | 4393 | 0.720 |
Why?
|
Health Care Reform | 2 | 2022 | 1245 | 0.720 |
Why?
|
Insurance Benefits | 3 | 2024 | 191 | 0.720 |
Why?
|
Hospitals, Rural | 1 | 2022 | 175 | 0.700 |
Why?
|
Morals | 1 | 2023 | 289 | 0.700 |
Why?
|
Hospitals, Urban | 1 | 2022 | 499 | 0.680 |
Why?
|
Rural Health | 1 | 2021 | 296 | 0.670 |
Why?
|
Income | 3 | 2024 | 1875 | 0.660 |
Why?
|
Coronary Disease | 2 | 2024 | 5991 | 0.650 |
Why?
|
Substance-Related Disorders | 5 | 2024 | 4371 | 0.650 |
Why?
|
Rural Health Services | 1 | 2022 | 381 | 0.640 |
Why?
|
Financing, Government | 1 | 2022 | 472 | 0.630 |
Why?
|
Heart Diseases | 2 | 2022 | 2809 | 0.620 |
Why?
|
Urban Health | 1 | 2021 | 533 | 0.620 |
Why?
|
Health Status Disparities | 5 | 2023 | 1829 | 0.610 |
Why?
|
Medicare Part D | 1 | 2023 | 354 | 0.610 |
Why?
|
Government Programs | 1 | 2020 | 280 | 0.600 |
Why?
|
Peripheral Arterial Disease | 3 | 2023 | 1305 | 0.590 |
Why?
|
Costs and Cost Analysis | 5 | 2023 | 1677 | 0.580 |
Why?
|
Food Supply | 1 | 2023 | 542 | 0.580 |
Why?
|
Endovascular Procedures | 4 | 2023 | 2134 | 0.580 |
Why?
|
Mandatory Reporting | 1 | 2018 | 124 | 0.570 |
Why?
|
Mortality | 5 | 2021 | 2916 | 0.570 |
Why?
|
Managed Care Programs | 1 | 2022 | 939 | 0.560 |
Why?
|
Male | 67 | 2024 | 359718 | 0.560 |
Why?
|
Health Services Misuse | 1 | 2019 | 245 | 0.560 |
Why?
|
Adult | 42 | 2024 | 220007 | 0.550 |
Why?
|
Workload | 3 | 2019 | 847 | 0.540 |
Why?
|
Hospital Costs | 3 | 2019 | 976 | 0.520 |
Why?
|
Physicians, Primary Care | 1 | 2022 | 624 | 0.520 |
Why?
|
Health Care Costs | 4 | 2024 | 3258 | 0.520 |
Why?
|
Ambulatory Care | 3 | 2024 | 2782 | 0.500 |
Why?
|
Female | 65 | 2024 | 391246 | 0.500 |
Why?
|
Embolectomy | 1 | 2016 | 129 | 0.490 |
Why?
|
Pandemics | 13 | 2024 | 8623 | 0.470 |
Why?
|
Cardiovascular Surgical Procedures | 3 | 2010 | 192 | 0.470 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.470 |
Why?
|
Cerebrovascular Disorders | 1 | 2021 | 1501 | 0.460 |
Why?
|
Choice Behavior | 2 | 2021 | 821 | 0.440 |
Why?
|
New York | 4 | 2020 | 875 | 0.430 |
Why?
|
Medically Uninsured | 5 | 2024 | 843 | 0.430 |
Why?
|
Disclosure | 1 | 2019 | 738 | 0.430 |
Why?
|
Patient Discharge | 9 | 2024 | 3474 | 0.420 |
Why?
|
Vena Cava Filters | 1 | 2016 | 261 | 0.420 |
Why?
|
International Classification of Diseases | 4 | 2022 | 894 | 0.420 |
Why?
|
Risk Assessment | 7 | 2024 | 24102 | 0.410 |
Why?
|
Coronary Angiography | 3 | 2020 | 4563 | 0.410 |
Why?
|
Mental Disorders | 2 | 2022 | 6796 | 0.410 |
Why?
|
Mediastinum | 2 | 2024 | 266 | 0.410 |
Why?
|
Middle Aged | 35 | 2024 | 220359 | 0.400 |
Why?
|
Sarcoidosis | 1 | 2017 | 520 | 0.400 |
Why?
|
Risk Factors | 19 | 2024 | 74333 | 0.400 |
Why?
|
American Heart Association | 5 | 2024 | 1081 | 0.390 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2003 | 0.390 |
Why?
|
Quality Improvement | 3 | 2022 | 3835 | 0.390 |
Why?
|
Retrospective Studies | 31 | 2024 | 80345 | 0.380 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2108 | 0.380 |
Why?
|
Lipids | 1 | 2022 | 3336 | 0.380 |
Why?
|
Registries | 10 | 2023 | 8458 | 0.370 |
Why?
|
Cardiology Service, Hospital | 3 | 2018 | 242 | 0.370 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3332 | 0.370 |
Why?
|
Brain Ischemia | 1 | 2024 | 3127 | 0.350 |
Why?
|
Aged, 80 and over | 20 | 2024 | 58980 | 0.350 |
Why?
|
Anticoagulants | 3 | 2016 | 4897 | 0.340 |
Why?
|
Minority Groups | 5 | 2024 | 1201 | 0.340 |
Why?
|
Coronary Artery Disease | 3 | 2024 | 6659 | 0.340 |
Why?
|
Task Performance and Analysis | 3 | 2010 | 759 | 0.330 |
Why?
|
Florida | 3 | 2020 | 430 | 0.330 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2011 | 179 | 0.330 |
Why?
|
Nutrition Surveys | 4 | 2024 | 1725 | 0.330 |
Why?
|
Residence Characteristics | 5 | 2022 | 2061 | 0.330 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3085 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3205 | 0.310 |
Why?
|
Critical Illness | 2 | 2017 | 2709 | 0.300 |
Why?
|
Paraproteinemias | 1 | 2010 | 246 | 0.300 |
Why?
|
Cost Savings | 3 | 2024 | 920 | 0.300 |
Why?
|
Treatment Outcome | 14 | 2024 | 64981 | 0.290 |
Why?
|
Operating Rooms | 3 | 2010 | 789 | 0.280 |
Why?
|
Warfarin | 2 | 2015 | 1518 | 0.280 |
Why?
|
Insurance Coverage | 3 | 2024 | 1939 | 0.280 |
Why?
|
Telemedicine | 1 | 2023 | 3018 | 0.260 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2420 | 0.260 |
Why?
|
Home Care Services | 2 | 2024 | 654 | 0.260 |
Why?
|
Cohort Studies | 10 | 2024 | 41337 | 0.260 |
Why?
|
Time Factors | 12 | 2024 | 40139 | 0.260 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2167 | 0.260 |
Why?
|
Cardiomyopathies | 1 | 2017 | 1951 | 0.260 |
Why?
|
Poland | 2 | 2024 | 196 | 0.250 |
Why?
|
Prevalence | 5 | 2023 | 15686 | 0.240 |
Why?
|
Cardiopulmonary Bypass | 1 | 2010 | 1096 | 0.240 |
Why?
|
Echocardiography | 4 | 2018 | 4981 | 0.240 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6853 | 0.230 |
Why?
|
Limb Salvage | 2 | 2023 | 465 | 0.230 |
Why?
|
Cholesterol | 2 | 2024 | 2924 | 0.230 |
Why?
|
Inflation, Economic | 1 | 2023 | 28 | 0.220 |
Why?
|
Outpatients | 2 | 2024 | 1607 | 0.220 |
Why?
|
Viscera | 1 | 2024 | 138 | 0.220 |
Why?
|
Antihypertensive Agents | 2 | 2024 | 2061 | 0.220 |
Why?
|
Risk | 4 | 2021 | 9632 | 0.210 |
Why?
|
Hospital Bed Capacity | 2 | 2020 | 210 | 0.210 |
Why?
|
Diagnosis-Related Groups | 1 | 2024 | 450 | 0.200 |
Why?
|
Pharmaceutical Services | 1 | 2024 | 141 | 0.200 |
Why?
|
Health Services Research | 2 | 2020 | 1810 | 0.200 |
Why?
|
Quality of Life | 1 | 2024 | 13308 | 0.200 |
Why?
|
Policy | 2 | 2023 | 511 | 0.200 |
Why?
|
Clinical Coding | 2 | 2020 | 181 | 0.200 |
Why?
|
Adolescent | 8 | 2024 | 87809 | 0.190 |
Why?
|
Cause of Death | 3 | 2021 | 3725 | 0.190 |
Why?
|
Preventive Health Services | 2 | 2024 | 570 | 0.190 |
Why?
|
Socioeconomic Factors | 5 | 2021 | 7805 | 0.190 |
Why?
|
Age Factors | 5 | 2021 | 18413 | 0.190 |
Why?
|
Young Adult | 7 | 2024 | 58748 | 0.190 |
Why?
|
Food Handling | 3 | 2006 | 155 | 0.190 |
Why?
|
Retirement | 1 | 2022 | 199 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11345 | 0.180 |
Why?
|
State Government | 1 | 2024 | 380 | 0.180 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2023 | 150 | 0.180 |
Why?
|
Neprilysin | 1 | 2023 | 472 | 0.180 |
Why?
|
Endocarditis | 1 | 2024 | 351 | 0.170 |
Why?
|
Angina Pectoris | 1 | 2024 | 969 | 0.170 |
Why?
|
Population Density | 1 | 2020 | 192 | 0.170 |
Why?
|
Social Responsibility | 1 | 2022 | 386 | 0.170 |
Why?
|
Motivation | 2 | 2020 | 1993 | 0.170 |
Why?
|
Nursing Staff | 1 | 2020 | 113 | 0.170 |
Why?
|
Episode of Care | 1 | 2019 | 127 | 0.160 |
Why?
|
Communication | 4 | 2020 | 3849 | 0.160 |
Why?
|
Health Facilities | 1 | 2024 | 578 | 0.160 |
Why?
|
Drugs, Generic | 1 | 2024 | 448 | 0.160 |
Why?
|
Life Style | 2 | 2024 | 3898 | 0.160 |
Why?
|
Survival Rate | 4 | 2020 | 12810 | 0.150 |
Why?
|
Aortic Valve Stenosis | 2 | 2022 | 2065 | 0.150 |
Why?
|
Michigan | 1 | 2019 | 342 | 0.150 |
Why?
|
Washington | 1 | 2018 | 312 | 0.150 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 584 | 0.150 |
Why?
|
Mental Health | 2 | 2022 | 3213 | 0.150 |
Why?
|
New York City | 1 | 2020 | 724 | 0.150 |
Why?
|
Databases, Factual | 5 | 2024 | 8022 | 0.150 |
Why?
|
Drug Utilization | 2 | 2020 | 1195 | 0.150 |
Why?
|
Hospital Administration | 1 | 2021 | 355 | 0.140 |
Why?
|
Meat Products | 3 | 2006 | 96 | 0.140 |
Why?
|
Obesity | 3 | 2024 | 12919 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1207 | 0.140 |
Why?
|
Patient Care | 1 | 2022 | 624 | 0.140 |
Why?
|
Physician Incentive Plans | 1 | 2018 | 165 | 0.140 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21029 | 0.130 |
Why?
|
Atrioventricular Block | 1 | 2017 | 121 | 0.130 |
Why?
|
Hypercholesterolemia | 1 | 2023 | 1155 | 0.130 |
Why?
|
Bradycardia | 1 | 2017 | 299 | 0.130 |
Why?
|
Medical Records | 2 | 2018 | 1407 | 0.130 |
Why?
|
Bundle-Branch Block | 1 | 2017 | 281 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2021 | 696 | 0.130 |
Why?
|
Lower Extremity | 1 | 2023 | 1193 | 0.130 |
Why?
|
Politics | 1 | 2022 | 814 | 0.130 |
Why?
|
Comorbidity | 5 | 2024 | 10553 | 0.120 |
Why?
|
Ontario | 3 | 2022 | 404 | 0.120 |
Why?
|
Ischemia | 1 | 2023 | 1893 | 0.120 |
Why?
|
Certification | 1 | 2018 | 421 | 0.120 |
Why?
|
Interprofessional Relations | 3 | 2010 | 989 | 0.120 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5209 | 0.120 |
Why?
|
Syncope | 1 | 2017 | 428 | 0.120 |
Why?
|
California | 1 | 2019 | 1416 | 0.120 |
Why?
|
Policy Making | 1 | 2018 | 538 | 0.120 |
Why?
|
Cost of Illness | 1 | 2024 | 1940 | 0.120 |
Why?
|
Pacemaker, Artificial | 1 | 2020 | 815 | 0.120 |
Why?
|
Patients | 1 | 2021 | 906 | 0.120 |
Why?
|
Practice Guidelines as Topic | 4 | 2024 | 7475 | 0.120 |
Why?
|
Prostate-Specific Antigen | 1 | 2024 | 2529 | 0.110 |
Why?
|
Massachusetts | 4 | 2020 | 8803 | 0.110 |
Why?
|
Urban Population | 1 | 2022 | 2022 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12289 | 0.110 |
Why?
|
Leadership | 3 | 2020 | 1371 | 0.110 |
Why?
|
Multiple Myeloma | 1 | 2011 | 5131 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1399 | 0.110 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 1067 | 0.100 |
Why?
|
Nursing Homes | 1 | 2020 | 1082 | 0.100 |
Why?
|
Guideline Adherence | 3 | 2018 | 2283 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1784 | 0.100 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2017 | 571 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1528 | 0.100 |
Why?
|
Health Resources | 1 | 2018 | 935 | 0.100 |
Why?
|
Prognosis | 5 | 2021 | 29661 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 413 | 0.100 |
Why?
|
History, 21st Century | 1 | 2018 | 1575 | 0.100 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5508 | 0.100 |
Why?
|
Internet | 1 | 2023 | 3078 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2608 | 0.090 |
Why?
|
Medical Errors | 2 | 2010 | 1255 | 0.090 |
Why?
|
Catheter Ablation | 1 | 2024 | 2758 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2021 | 3985 | 0.090 |
Why?
|
Length of Stay | 2 | 2021 | 6476 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15840 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2020 | 1499 | 0.090 |
Why?
|
Catheterization | 1 | 2016 | 1432 | 0.090 |
Why?
|
Dentures | 1 | 2010 | 12 | 0.090 |
Why?
|
Information Dissemination | 1 | 2018 | 1131 | 0.090 |
Why?
|
Exercise Test | 1 | 2017 | 2128 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2773 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3202 | 0.080 |
Why?
|
Blood Glucose | 1 | 2024 | 6379 | 0.080 |
Why?
|
Food Packaging | 2 | 2006 | 13 | 0.080 |
Why?
|
Branchioma | 1 | 2008 | 17 | 0.080 |
Why?
|
Aerospace Medicine | 1 | 2010 | 95 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2007 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10546 | 0.080 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2008 | 25 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2015 | 987 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7268 | 0.080 |
Why?
|
Insulin | 1 | 2022 | 6596 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2634 | 0.070 |
Why?
|
Public Health | 1 | 2021 | 2653 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3448 | 0.070 |
Why?
|
Ownership | 2 | 2020 | 339 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3310 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2642 | 0.070 |
Why?
|
Emergency Service, Hospital | 3 | 2024 | 7818 | 0.070 |
Why?
|
Administration, Oral | 1 | 2014 | 4035 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15286 | 0.070 |
Why?
|
Prospective Studies | 5 | 2024 | 54306 | 0.060 |
Why?
|
Foreign Bodies | 1 | 2010 | 397 | 0.060 |
Why?
|
Morbidity | 2 | 2021 | 1765 | 0.060 |
Why?
|
Escherichia coli O157 | 1 | 2005 | 53 | 0.060 |
Why?
|
Sex Distribution | 1 | 2010 | 2294 | 0.060 |
Why?
|
Larynx | 1 | 2010 | 492 | 0.060 |
Why?
|
Salmonella | 1 | 2005 | 126 | 0.060 |
Why?
|
Equipment Contamination | 1 | 2006 | 179 | 0.060 |
Why?
|
Food Contamination | 1 | 2006 | 192 | 0.060 |
Why?
|
Deafness | 1 | 2008 | 457 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6415 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2010 | 1440 | 0.060 |
Why?
|
Ukraine | 1 | 2024 | 137 | 0.060 |
Why?
|
Streptococcus pyogenes | 1 | 2006 | 294 | 0.060 |
Why?
|
Listeria monocytogenes | 1 | 2005 | 248 | 0.060 |
Why?
|
Diuresis | 1 | 2023 | 107 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3696 | 0.060 |
Why?
|
Incidence | 3 | 2024 | 21391 | 0.060 |
Why?
|
Education, Medical | 1 | 2015 | 1727 | 0.050 |
Why?
|
Chickens | 1 | 2005 | 860 | 0.050 |
Why?
|
Thoracic Surgery | 1 | 2009 | 725 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2017 | 1578 | 0.050 |
Why?
|
Meat | 1 | 2005 | 584 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6465 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2008 | 1415 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 2 | 2024 | 3620 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3865 | 0.050 |
Why?
|
Colony Count, Microbial | 3 | 2006 | 328 | 0.050 |
Why?
|
Translating | 1 | 2022 | 148 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 388 | 0.050 |
Why?
|
Patient Care Team | 2 | 2010 | 2511 | 0.040 |
Why?
|
Diuretics | 1 | 2023 | 613 | 0.040 |
Why?
|
Preoperative Care | 1 | 2009 | 2255 | 0.040 |
Why?
|
Hot Temperature | 1 | 2005 | 1435 | 0.040 |
Why?
|
Hospitals, Veterans | 1 | 2021 | 398 | 0.040 |
Why?
|
Communication Barriers | 1 | 2022 | 415 | 0.040 |
Why?
|
Device Approval | 1 | 2020 | 165 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39262 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10185 | 0.040 |
Why?
|
Femoral Artery | 1 | 2022 | 831 | 0.040 |
Why?
|
Pulmonary Veins | 1 | 2024 | 745 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2008 | 2176 | 0.040 |
Why?
|
Sodium | 1 | 2023 | 1594 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13982 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2021 | 841 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 916 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2005 | 1462 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1031 | 0.030 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2020 | 498 | 0.030 |
Why?
|
Food Microbiology | 2 | 2006 | 76 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 730 | 0.030 |
Why?
|
Consumer Product Safety | 2 | 2006 | 123 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 934 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1004 | 0.030 |
Why?
|
Ileostomy | 1 | 2015 | 120 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3302 | 0.030 |
Why?
|
Disease Progression | 1 | 2011 | 13505 | 0.030 |
Why?
|
Fibrinolysis | 1 | 2015 | 332 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1385 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2018 | 528 | 0.030 |
Why?
|
Drug Approval | 1 | 2020 | 816 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1500 | 0.030 |
Why?
|
Regression Analysis | 1 | 2022 | 6359 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2020 | 2435 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.030 |
Why?
|
Enoxaparin | 1 | 2015 | 397 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4783 | 0.030 |
Why?
|
Language | 1 | 2022 | 1533 | 0.030 |
Why?
|
Thrombophilia | 1 | 2015 | 307 | 0.030 |
Why?
|
Aortic Valve | 1 | 2022 | 1996 | 0.030 |
Why?
|
Cognition | 1 | 2010 | 6964 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1405 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2024 | 3598 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4350 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2493 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36286 | 0.020 |
Why?
|
Time Management | 1 | 2010 | 52 | 0.020 |
Why?
|
Thrombectomy | 1 | 2015 | 708 | 0.020 |
Why?
|
Colectomy | 1 | 2015 | 692 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2022 | 3149 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5523 | 0.020 |
Why?
|
Pilot Projects | 2 | 2015 | 8556 | 0.020 |
Why?
|
Temperature | 2 | 2006 | 2221 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2015 | 1063 | 0.020 |
Why?
|
Animals | 4 | 2015 | 167960 | 0.020 |
Why?
|
Ear | 1 | 2008 | 172 | 0.020 |
Why?
|
Observation | 1 | 2010 | 312 | 0.020 |
Why?
|
Minnesota | 1 | 2008 | 340 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2024 | 15679 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3242 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12531 | 0.020 |
Why?
|
Cheese | 1 | 2006 | 38 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12159 | 0.020 |
Why?
|
Tracheostomy | 1 | 2010 | 425 | 0.020 |
Why?
|
Vocal Cords | 1 | 2010 | 523 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13312 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12914 | 0.010 |
Why?
|
Safety Management | 1 | 2010 | 760 | 0.010 |
Why?
|
Software | 1 | 2018 | 4419 | 0.010 |
Why?
|
Causality | 1 | 2010 | 1242 | 0.010 |
Why?
|
Focus Groups | 1 | 2009 | 1378 | 0.010 |
Why?
|
Cooking | 1 | 2005 | 311 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1919 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26179 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3847 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36053 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5201 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42056 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12968 | 0.010 |
Why?
|
Kidney | 1 | 2008 | 7064 | 0.010 |
Why?
|
Child | 1 | 2020 | 79799 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20509 | 0.010 |
Why?
|
Models, Biological | 1 | 2005 | 9468 | 0.000 |
Why?
|